Amgen VP-Licensing Scott Foraker: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche’s Mircera has not impacted Amgen’s aggressiveness on pursuing deals, Foraker says.
You may also be interested in...
Amgen Bundling Discounts Will Continue As J&J Case Heads To Trial
Court denies injunction sought by J&J to stop Amgen discounts based on amount of anemia products purchased.
Amgen Bundling Discounts Will Continue As J&J Case Heads To Trial
Court denies injunction sought by J&J to stop Amgen discounts based on amount of anemia products purchased.
Amgen VP-Licensing Scott Foraker: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
Foraker advises competitors to “watch out” for new Amgen initiatives in Asia “in the coming months.”